UNIQURE N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.92 USD | -2.96% |
|
+4.90% | -27.33% |
| May. 08 | Mizuho Adjusts uniQure's Price Target to $6 From $7, Keeps Neutral Rating | MT |
| May. 07 | UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNIQURE N.V. | Bio Therapeutic Drugs | -2.96% | +4.90% | -27.33% | -77.84% | -91.95% | 239M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- QURE Stock
- Charts uniQure N.V.
- Comparison Chart
